Head-To-Head Comparison: Envoy Medical (COCH) vs. Its Competitors

Envoy Medical (NASDAQ:COCH) is one of 51 publicly-traded companies in the “Surgical appliances & supplies” industry, but how does it weigh in compared to its rivals? We will compare Envoy Medical to related companies based on the strength of its institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings.

Earnings & Valuation

This table compares Envoy Medical and its rivals top-line revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Envoy Medical	$225,000.00	-$29.91 million	-0.91
Envoy Medical Competitors	$1.41 billion	$234.66 million	13.87

Envoy Medical’s rivals have higher revenue and earnings than Envoy Medical. Envoy Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Profitability

This table compares Envoy Medical and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-7,607.55%	N/A	-262.28%
Envoy Medical Competitors	-169.94%	-74.14%	-20.85%

Analyst Ratings

This is a summary of recent ratings and target prices for Envoy Medical and its rivals, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	0	0	2	0	3.00
Envoy Medical Competitors	400	1402	2526	116	2.53

Envoy Medical presently has a consensus target price of $9.00, indicating a potential upside of 603.13%. As a group, “Surgical appliances & supplies” companies have a potential upside of 31.37%. Given Envoy Medical’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Envoy Medical is more favorable than its rivals.

Institutional and Insider Ownership

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 45.5% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 60.5% of Envoy Medical shares are held by insiders. Comparatively, 10.2% of shares of all “Surgical appliances & supplies” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Risk and Volatility

Envoy Medical has a beta of 2.35, indicating that its stock price is 135% more volatile than the S&P 500. Comparatively, Envoy Medical’s rivals have a beta of 1.28, indicating that their average stock price is 28% more volatile than the S&P 500.

Summary

Envoy Medical rivals beat Envoy Medical on 7 of the 13 factors compared.

About Envoy Medical

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.